K(ATP) channels and MPTP are involved in the cardioprotection bestowed by chronic intermittent hypobaric hypoxia in

Hui-min Bu1, Chang-ying Yang, Mei-ling Wang

  • 1Department of Physiology, Hebei Medical University, Shijiazhuang, 050017, China.

Insights

Chronic intermittent hypobaric hypoxia (CIHH) enhances heart protection against ischemia/reperfusion (I/R) injury in developing rats. This cardioprotection involves opening ATP-sensitive potassium (KATP) channels and inhibiting mitochondrial permeability transition pore (MPTP) opening.

Area of Science:

  • Cardiovascular Physiology
  • Altitude Medicine
  • Mitochondrial Biology

Background:

  • Ischemia/reperfusion (I/R) injury poses a significant threat to cardiac health, particularly in developing organisms.
  • Chronic intermittent hypobaric hypoxia (CIHH) is a potential preconditioning strategy to mitigate cardiac damage.
  • Understanding the underlying molecular mechanisms of CIHH-induced cardioprotection is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the protective mechanisms of CIHH against I/R injury in the hearts of developing rats.
  • To elucidate the roles of ATP-sensitive potassium (KATP) channels and mitochondrial permeability transition pore (MPTP) in CIHH-mediated cardioprotection.

Main Methods:

  • Neonatal male rats were exposed to CIHH simulating 3000m altitude for 28 or 42 days.
  • Isolated heart function was assessed, along with myocardial ultra-microstructure, superoxide dismutase (SOD) activity, and total anti-oxidation capacity (TAC).
  • Pharmacological agents targeting KATP channels and MPTP were used to probe the protective pathways.

Main Results:

  • CIHH exposure improved recovery of cardiac function post-I/R and increased coronary flow without altering basic left ventricular function.
  • CIHH rats exhibited elevated SOD levels and TAC, with reduced mitochondrial ultra-structure damage compared to controls.
  • Cardioprotection was abolished by KATP channel inhibitors (glibenclamide, 5-hydroxydecanoate) and an MPTP opener (atractyloside).
  • Conversely, an MPTP blocker (cyclosporin A) and a mitoKATP opener (diazoxide) conferred protection in control rats.

Conclusions:

  • CIHH confers significant cardioprotection against I/R injury in developing rats.
  • This protection is mediated by the activation of ATP-sensitive potassium (KATP) channels, particularly mitochondrial KATP (mitoKATP) channels.
  • Inhibition of mitochondrial permeability transition pore (MPTP) opening is a key downstream event in CIHH-induced cardioprotection.

Related Concept Videos